Mucomyst W/ Isoproterenol

   
Google
 
Web NewDrugInformation.com

Mucomyst W/ Isoproterenol


Drug - Mucomyst W/ Isoproterenol
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; INHALATION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetylcysteine; Isoproterenol Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 10%;0.05%
The potency of the active ingredient(s), Acetylcysteine; Isoproterenol Hydrochloride. May repeat for multiple part products.

Applicant - MEAD JOHNSON
The firm name holding legal responsibility for Mucomyst W/ Isoproterenol. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 017366
The FDA assigned number to Mucomyst W/ Isoproterenol. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Mucomyst W/ Isoproterenol. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Mucomyst W/ Isoproterenol was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Mucomyst W/ Isoproterenol. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Mucomyst W/ Isoproterenol is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mead Johnson And Co Sub Bristol Myers Co
The full name of the firm holding legal responsibility for the new application of Mucomyst W/ Isoproterenol.

Mucomyst W/ Isoproterenol